Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(11 sites)

France

Institut de Cancérologie de l'Ouest, Angers

CHU Bordeaux, Bordeaux

Centre François Baclesse, Caen

CHU Grenoble, Grenoble

Polyclinique Chenieux, Limoges

Centre Léon Bérard, Lyon

"L'Hôpital Privé du Confluent ", Nantes

Centre Antoine Lacassagne, Nice

Institut de Cancérologie de l'Ouest, Saint-Herblain

Institut de Cancérologie Strasbourg Europe, Strasbourg

Institut Claudius Regaud -IUCT-O, Toulouse